$MRNA big void to fill from low $50s to $65, before getting back UPtrend $75+
@CNBCFastMoney @SquawkStreet @jimcramer $ibb $xbi $ino $nvax $jnj #moderna_tx huge winner in getting pioneering RNA tech into human Ph1 + Ph2 #Covid19Vaccine and core pipeline is still not fully valued. https://t.co/4a2vW8TKhe